- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01687803
Evaluating the Health Benefits of Physical Activity Recommendations in the Dietary Guidelines (FL52)
September 13, 2012 updated by: USDA, Western Human Nutrition Research Center
The overall goal of this study is to determine the health benefits associated with the 2005 Dietary Guidelines physical activity prescription in healthy, peri-menopausal women.
The 2005 Dietary Guidelines specifically state that to avoid unhealthy weight gain, adults should participate in 60 minutes of moderate to vigorous intensity physical activity on most days of the week.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study will be a randomized controlled trial conducted over a 6 to 7 month period. Subjects will be enrolled by cohorts and randomly assigned to one of two groups.
- Group 1 (PA): physical activity intervention that will consist of brisk walking or other aerobic-type activities (6 days per week), resistance exercise (using free weights, resistance bands or weight stacks for weight lifting, 3 days per week), and 'active lifestyle' activities such as gardening, dancing, participation in sporting activities. The total time spent in these activities will add up to ~60 min/day for 6 days/week (~360 minutes per week).
- Group 2 (CON): control group will maintain their usual level of physical activity and participate in testing protocols, record keeping, and interviews on the same schedule as PA. This group will be offered an opportunity to have a gym membership/access to the training facility after completion of the 6-month period of serving as controls.
The specific aims of this pilot study are to:
- Assess each participant's level of compliance/adherence
- Assess the dietary habits of study participants as they become more physically active.
- Identify barriers to physical activity in this specific population.
- Measure changes in body composition, physical fitness and energy expenditure.
- Evaluate changes in chronic disease risk factors.
- Determine if regular physical activity reduces chronic stress.
Study Type
Interventional
Enrollment (Actual)
37
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
42 years to 52 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Body Mass Index: 18.5 to 29.9 kg/m2
- Peri-menopause, as determined by self-report of menstrual history and symptoms for previous 12 months
- Sedentary lifestyle
Exclusion Criteria:
- Individuals who are already physically active
- Pregnant or nursing within the last 6 months
- Plan to become pregnant during the study
- Musculoskeletal disease or disorder which is expected to limit participation in physical activity
- Orthopedic injuries
- Inflammatory arthritis or autoimmune disorders
- Neuromuscular disorders including multiple sclerosis, amyotrophic lateral sclerosis, Parkinson's disease
- Menopause confirmed
- Use of tobacco products
- Family history of premature cardiovascular disease as defined by the ACSM guidelines
- Cardiovascular including a history of cardiac arrest; coronary heart disease, complex ventricular arrhythmia or atrial arrhythmia at rest or with exercise, congestive heart failure, cardiomyopathy, hemodynamically significant valvular heart disease, left bundle block, cardiac pacemaker; implanted cardiac defibrillator; history of aortic aneurysm of at least 7 cm in diameter or aortic aneurysm repair; resting heart rate < 45 beats per minute or > 100 beats per minute
- Chronic lung disease resulting in dyspnea at rest or with minimal exertion, lung disease resulting in hypoxia or hypercapnia at rest or with exercise, pulmonary embolus within 6 months, active tuberculosis
- Presence of risk factors for cardiovascular or metabolic disease:
- Hypertension (SBP ≥140 mm Hg and/or DBP ≥ 90 mm Hg); hypertension treated by beta adrenergic blockers regardless of blood pressure
- Elevated fasting LDL cholesterol (≥160 mg/dL)
- Elevated fasting triglycerides (≥300 mg/dL)
- Diagnosed diabetes mellitus or elevated fasting glucose (≥126 mg/dL), adrenal disease, acromegaly, or thyroid disease requiring medication change or other treatment within the previous 3 months
- Weight change greater than 10 lbs in the preceding 6 months
- Medications: chronic corticosteroid use or need for oral corticosteroids more than twice in the last 12 months, antipsychotic medications, beta adrenergic blockers, medications for weight loss (including sibutramine, orlistat, phentermine, phendimetrazine, topiramate, zonisamide), immunosuppressants, amphetamines and other stimulants, and other medications known to influence body weight
- Travel plans that do not permit full participation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Physical Activity
Physical activity intervention will consist of brisk walking or other aerobic-type activities (6 days per week), resistance exercise (using free weights, resistance bands or weight stacks for weight lifting, 3 days per week), and 'active lifestyle' activities such as gardening, dancing, participation in sporting activities.
The total time spent in these activities will add up to ~60 min/day for 6 days/week (~360 minutes per week).
|
Physical activity intervention that will consist of brisk walking or other aerobic-type activities (6 days per week), resistance exercise (using free weights, resistance bands or weight stacks for weight lifting, 3 days per week), and 'active lifestyle' activities such as gardening, dancing, participation in sporting activities.
The total time spent in these activities will add up to ~60 min/day for 6 days/week (~360 minutes per week).
|
Other: Control
The control group will maintain their usual level of physical activity and participate in testing protocols, record keeping, and interviews.
|
The control group will maintain their usual level of physical activity and participate in testing protocols, record keeping, and interviews.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in compliance with exercise
Time Frame: 0, 3 and 6 months
|
The Actiheart (MiniMitter, Bend OR) physical activity and heart rate logger is a motion sensor and heart rate monitor worn by subjects 24 hours per day(excluding bathing and swimming) for one week to determine the level of physical activity.
Subjects will also use a pedometer to record the number of steps taken during their walking sessions.
The Stanford 7 day Physical Activity recall questionnaire will also be used to assess physical activity.
|
0, 3 and 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in dietary intake
Time Frame: 0, 6 months
|
The 24-hour dietary recall will be used to assess usual dietary intake.
Four recalls will be collected on non-consecutive days during the first and sixth months of the study.
Additionally, the Healthy Eating Index for diet quality will be used to score the diets of subjects.
|
0, 6 months
|
Change in body composition
Time Frame: 0, 3, and 6 months
|
Body Composition is measured by dual energy x-ray absorptiometry (DEXA) using a whole body scan.
|
0, 3, and 6 months
|
Change in Chronic Disease Risk Assessment
Time Frame: 0, 3 and 6 months
|
Chronic Disease Risk Assessment includes blood pressure, fasting blood cholesterol, HDL cholesterol, LDL cholesterol, triacylglycerides, non-esterified fatty acids, ApoAI, ApoAII, and ApoB, glucose, insulin.
Insulin sensitivity will be assessed by the homeostatic model utilizing fasting insulin and glucose values (fasting plasma insulin (mU/ml) X fasting plasma glucose (mmol/L)/22.5).
High sensitivity C-Reactive Protein, inflammatory cytokines including IL-6 and TNF-α, Oxylipins and other markers of oxidative stress such as oxygen radical absorptive capacity will be analyzed in plasma samples.
|
0, 3 and 6 months
|
Change in measures of stress
Time Frame: 0, 3 and 6 months
|
At baseline and after three and six months of the exercise intervention participants will be asked to collect saliva samples for the assessment of salivary cortisol.
|
0, 3 and 6 months
|
Change in aerobic fitness
Time Frame: 0, 3, and 6 months
|
Maximal aerobic capacity is measured using a walking graded treadmill test.
Indirect calorimetry will be used to measure oxygen consumption and carbon dioxide production continuously during the exercise test.
|
0, 3, and 6 months
|
Change in measures of muscle strength
Time Frame: 0, 3, and 6 months
|
Peak strength and muscle endurance of the musculature of the knee and shoulder will be measured using an isokinetic dynamometer.
A measure of the maximum weight that can be moved for a single repetition (1-RM) will be measured.
|
0, 3, and 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Nancy L Keim, PhD, USDA, ARS, Western Human Nutrition Research Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2006
Primary Completion (Actual)
September 1, 2009
Study Completion (Actual)
September 1, 2011
Study Registration Dates
First Submitted
September 11, 2012
First Submitted That Met QC Criteria
September 13, 2012
First Posted (Estimate)
September 19, 2012
Study Record Updates
Last Update Posted (Estimate)
September 19, 2012
Last Update Submitted That Met QC Criteria
September 13, 2012
Last Verified
September 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 200614442-2
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Fundació Sant Joan de DéuRecruitingObesity, Childhood | Obesity, AdolescentSpain
Clinical Trials on Physical Activity
-
Health Education Research Foundation (HERF)CompletedQuality of LifePakistan
-
Zohra Institute of Health SciencesCompletedPhysical Activity and StressPakistan
-
Centre Hospitalier Universitaire DijonWithdrawn
-
Fundacion para la Investigacion y Formacion en...CompletedImpaired CognitionSpain
-
AUSL Romagna RiminiFondazione IRCCS Istituto Nazionale dei Tumori, MilanoRecruitingNon-Small Cell Lung CancerItaly
-
Fundación para la Investigación del Hospital Clínico...CompletedObesity | Severe Mental Disorder
-
Augusta UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Kansas... and other collaboratorsCompletedMental Disorders, SevereUnited States
-
Centre Hospitalier Departemental VendeeTerminated
-
Rio de Janeiro State UniversityCompleted
-
University of California, San DiegoRecruitingCognitive Change | Aging | Mild Cognitive Impairment | Cognitive Decline | Memory Disorders | Memory Impairment | Cognition Disorders in Old Age | Aging Problems | Memory Loss | Memory Disorders in Old Age | Memory Disorder, SpatialUnited States